checkAd
    Startseite > Aktien > Resmed > Nachrichten
    Resmed Aktie
    199,25
     
    EUR
    -1,21 %
    -2,45 EUR
    Letzter Kurs 09:53:44 Tradegate
    198,65
     
    EUR
    50 STK
    Geldkurs 12:35:19
    200,60
     
    EUR
    50 STK
    Briefkurs 12:35:19
    ISIN: US7611521078 · WKN: 895878 · SYM: RME · USA

    Neueste Nachrichten

    ATS 2024: New ResMed-Supported Research Shows Increasing Prevalence of Obstructive Sleep Apnea and Critical Role of PAP Therapy
    16.05.24 · globenewswire · Resmed
    ResMed Announces Participation in the RBCCM Global Healthcare Conference
    07.05.24 · globenewswire · Resmed
    Der Börsen-Tag: Positive Tendenz bei Indizes: SDAX und TecDAX führen mit starken Zuwächsen
    26.04.24 · wO Newsflash · American Express
    ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2024
    25.04.24 · globenewswire · Resmed
    Der Börsen-Tag: Marktbericht: DAX, SDAX, Dow Jones und S&P 500 im Plus, MDAX und TecDAX verlieren
    17.04.24 · wO Newsflash · Carl Zeiss Meditec
    ResMed to Report Third Quarter Fiscal 2024 Earnings on April 25, 2024
    04.04.24 · globenewswire · Resmed
    ResMed's 2024 Global Sleep Survey Uncovers a World in Sleep Crisis
    15.03.24 · globenewswire · Resmed
    Der Börsen-Tag: Marktbericht: Dow Jones trotzt Abwärtstrend - Top- und Flopwerte im Überblick
    08.03.24 · wO Newsflash · Carl Zeiss Meditec
    Introducing the AirFit F40: Experience Unprecedented Freedom with the Comfort and Optimized Seal Performance of ResMed’s Smallest Full-Face CPAP Mask
    06.03.24 · globenewswire · Resmed
    ResMed’s New AirCurve 11 Bilevel Devices Enable Healthcare Providers to Make Informed Decisions about Care, Deliver Personalized Support, and Drive Positive Therapy Outcomes for Patients with Sleep Apnea
    12.02.24 · globenewswire · Resmed
    ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2024
    24.01.24 · globenewswire · Resmed
    ResMed to Report Second Quarter Fiscal 2024 Earnings on January 24, 2024
    03.01.24 · globenewswire · Resmed